Page last updated: 2024-08-24

emtricitabine and Amphetamine-Related Disorders

emtricitabine has been researched along with Amphetamine-Related Disorders in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Azariah, S; Coughlan, E; Giola, M; Ludlam, A; Myers, J; O'Toole, C; Pohl, M; Rich, J; Saxton, P	1

Other Studies

1 other study(ies) available for emtricitabine and Amphetamine-Related Disorders

Article	Year
Implementing HIV pre-exposure prophylaxis (PrEP): let's not get caught with our pants down. The New Zealand medical journal, 2018, 08-31, Volume: 131, Issue:1481 Topics: Amphetamine-Related Disorders; Anti-HIV Agents; Cost-Benefit Analysis; Drug Combinations; Emtricitabine; Female; Healthcare Disparities; HIV Infections; Humans; Male; Morals; Patient Selection; Pre-Exposure Prophylaxis; Risk Factors; Sexual and Gender Minorities; Sexual Partners; Tenofovir; Transgender Persons; Treatment Outcome; Unsafe Sex; Vulnerable Populations	2018

Article

Year

Implementing HIV pre-exposure prophylaxis (PrEP): let's not get caught with our pants down.

The New Zealand medical journal, 2018, 08-31, Volume: 131, Issue:1481

Topics: Amphetamine-Related Disorders; Anti-HIV Agents; Cost-Benefit Analysis; Drug Combinations; Emtricitabine; Female; Healthcare Disparities; HIV Infections; Humans; Male; Morals; Patient Selection; Pre-Exposure Prophylaxis; Risk Factors; Sexual and Gender Minorities; Sexual Partners; Tenofovir; Transgender Persons; Treatment Outcome; Unsafe Sex; Vulnerable Populations

2018